CALITHERA BIOSCIENCES INC CALA

$0.00 -66.67% at last close

Analyst Consensus

Recent Analyst Actions

DateFirmActionRatingPrice Target
2022-11-15
Ladenburg ThalmannAydin Huseynov
Downgrades Buy → Neutral
2022-11-15
SVB LeerinkJonathan Chang
Downgrades Outperform → Market perform $18 → $2
2022-08-29
HC Wainwright & Co.Swayampakula Ramakanth
Upgrades Neutral → Buy $8
2022-08-16
SVB LeerinkJonathan Chang
Maintains Outperform $2 → $18
2022-05-11
Wells FargoNick Abbott
Maintains Equal-weight $60 → $40
2022-04-04
SVB LeerinkJonathan Chang
Maintains Outperform $60 → $40
2022-01-31
Ladenburg ThalmannAydin Huseynov
Initiates coverage on Buy $80
2022-01-20
SVB LeerinkJonathan Chang
Upgrades Market perform → Outperform $20 → $60
2021-11-08
HC Wainwright & Co.Swayampakula Ramakanth
Downgrades Buy → Neutral
2021-11-05
William BlairMatt Phipps
Downgrades Outperform → Market perform
2021-01-05
HC Wainwright & Co.Swayampakula Ramakanth
Maintains Buy $190 → $80
2021-01-05
SVB LeerinkJonathan Chang
Downgrades Outperform → Market perform $140 → $40
2020-08-11
SVB LeerinkJonathan Chang
Maintains Outperform $180 → $140
2020-05-08
HC Wainwright & Co.
Reiterates Buy $140 → $190
2020-03-27
CitigroupMohit Bansal
Maintains Buy $160 → $140
2020-03-27
JefferiesBiren Amin
Initiates coverage on Buy $120
2019-11-19
HC Wainwright & Co.
Initiates coverage on Buy $140
2019-05-30
CitigroupMohit Bansal
Assumes Buy $200
2018-02-16
CitigroupRobyn Karnauskas
Upgrades Neutral → Buy
2017-10-05
William BlairMatt Phipps
Initiates coverage on Outperform
2017-03-28
HC Wainwright & Co.Shaunak Deepak
Maintains Buy $200 → $280
2017-01-24
CitigroupRobyn Karnauskas
Upgrades Sell → Neutral
2016-10-25
CitigroupRobyn Karnauskas
Initiates coverage on Sell
2016-03-09
JMP Securities
Maintains Market outperform $400 → $240
2015-07-24
Citigroup
Initiates coverage on Buy $220
2015-01-28
Citigroup
Maintains Buy $300 → $600
2014-10-27
Citigroup
Initiates coverage on Buy $300
2014-10-27
JMP Securities
Initiates coverage on Market outperform $400
2014-10-27
Wells FargoNick Abbott
Initiates coverage on Outperform
2014-10-27
Leerink Swann
Initiates coverage on Outperform $260

Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.

Key Stats

Last Close
$0.00
Market Cap
52-Week Range
$0.00 $0.00
Average Volume
1K shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.